◀ Back to SMAD1
SMAD1 — SMAD9
Pathways - manually collected, often from reviews:
-
KEGG TGF-beta signaling pathway:
Complex of SMAD1-SMAD4-SMAD5-SMAD9
→
ID1/ID2/ID3/ID4
(gene expression, expression)
-
KEGG TGF-beta signaling pathway:
MAPK1/MAPK3
→
Complex of SMAD1-SMAD4-SMAD5-SMAD9
(protein-protein, inhibition)
-
NCI Pathway Database ALK2 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Visser et al., Mol Endocrinol 2001, Clarke et al., Mol Endocrinol 2001
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Scharpfenecker et al., J Cell Sci 2007, Macías-Silva et al., J Biol Chem 1998, Chen et al., J Biol Chem 1999
Evidence: assay
-
NCI Pathway Database ALK2 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Macías-Silva et al., J Biol Chem 1998, Chen et al., J Biol Chem 1999
Evidence: assay, physical interaction
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Lee et al., FASEB J 2009
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK2 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD4/SMAD1-5-8 (dimer) complex (SMAD4-SMAD1_SMAD9_SMAD5)
(modification, collaborate)
Visser et al., Mol Endocrinol 2001, Clarke et al., Mol Endocrinol 2001, Macías-Silva et al., J Biol Chem 1998
Evidence: assay
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD4/SMAD1-5-8 (dimer) complex (SMAD4-SMAD1_SMAD9_SMAD5)
(modification, collaborate)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD4/SMAD1-5-8 (dimer) complex (SMAD4-SMAD1_SMAD9_SMAD5)
(modification, collaborate)
Scharpfenecker et al., J Cell Sci 2007, Chen et al., J Biol Chem 1999
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
David et al., Blood 2007, Scharpfenecker et al., J Cell Sci 2007
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Oh et al., Proc Natl Acad Sci U S A 2000, Goumans et al., EMBO J 2002, Goumans et al., Mol Cell 2003, Lebrin et al., EMBO J 2004, Blanco et al., J Cell Physiol 2005, Valdimarsdottir et al., BMC cell biology 2006, Santibanez et al., Cardiovasc Res 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database ALK1 signaling events:
SMAD1-5-8-active (SMAD1/SMAD9/SMAD5)
→
SMAD1-5-8 (SMAD1/SMAD9/SMAD5)
(modification, collaborate)
Lee et al., FASEB J 2009, Macías-Silva et al., J Biol Chem 1998
Evidence: mutant phenotype
-
WikiPathways ESC Pluripotency Pathways:
Complex of SMAD5-SMAD1-SMAD9-SMAD4
→
Complex of SMAD1-SMAD5-SMAD9-SMAD4
(activation)
-
WikiPathways ESC Pluripotency Pathways:
Complex of SMAD5-SMAD1-SMAD9-SMAD4
→
MAPK7/MAPK1/MAPK6/MAPK4/MAPK12
(inhibition)
-
WikiPathways ESC Pluripotency Pathways:
SMAD1/SMAD5/SMAD9
→
Complex of SMAD5-SMAD1-SMAD9-SMAD4
(activation)
-
WikiPathways ESC Pluripotency Pathways:
SMAD5/SMAD1/SMAD9
→
SMAD1/SMAD5/SMAD9
(activation)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
Gene Ontology Complexes transcription factor complex:
transcription factor complex complex (ATF7IP-GSC-GCM1-MAFB-NKX2-1-NKX2-5-RARG-KLF4-FOXF1-FOXF2-FOXE3-LDB1-ZFHX3-GATA6-SNAI3-FOXH1-KAT5-AHR-EYA3-NFATC2-CRX-MED27-HES6-SKI-XRCC6-ARNTL-SUB1-JUN-SOX17-SCX-DMBX1-TCF4-TCF7-PDLIM1-TFEB-LBX1-TRRAP-NAA16-EPAS1-MGA-PTF1A-HOXD12-MEF2B-TFDP3-TFDP1-HDAC2-YY1-SMAD9-CLOCK-ONECUT3-SMAD5-SMAD6-SMAD7-SMAD1-SMAD2-PRKDC-RCOR2-NHLH2-REL-TBX5-ARNTL2-BSX-HOXA10-HOXB13-MED23-PUS1-TAL1-RBL1-RBL2-MINA-HMGA1-BARX2-LEF1-EP300-PMF1-ARID5A-WWTR1-LMO2-LMO4-TP73-ABT1-CDK2-DKFZp686M216-CREG1-CTNNB1-SOX9-HAND2-SOX2-TEAD2-MYOG-TEAD4-CEBPA-GFI1B-MYOD1-ALX1-NPAS4-TFAP2D-FIGLA-ALX4-ETS1-PROP1-ASCL3-HCLS1-MSX1-MSX2-SRA1-AJUBA-MTA2-SIN3A-POU3F2-POU3F1-BEX1-MLXIPL-NR2E3-PBX2-ANKRD1-E2F6-E2F5-E2F4-E2F3-E2F2-E2F1-E2F8-CREBBP-ATF5-ATF4-POU2F3)
Kaspar et al., J Biol Chem 1999, Wang et al., J Biol Chem 1999, Nagpal et al., J Biol Chem 1999, Blixt et al., Genes Dev 2000, Carlberg et al., Mol Cell Biol Res Commun 2000, Bae et al., Development 2000, Cairo et al., Hum Mol Genet 2001, Tutter et al., Genes Dev 2001, Willis et al., J Biol Chem 2002, Bayne et al., Mol Hum Reprod 2004, Schubert et al., J Biol Chem 2004, Han et al., J Mol Biol 2005, Rodriguez et al., EMBO J 2005, Han et al., Nucleic Acids Res 2005, Zhang et al., Mol Cell Biol 2007, Wong et al., Cell 2009, Stevens et al., Immunology 2009, Stefanovic et al., J Cell Biol 2009, Skokowa et al., Nat Med 2012, Ge et al., Cell 1994, Durocher et al., EMBO J 1997, Hogenesch et al., Proc Natl Acad Sci U S A 1998, Hellqvist et al., J Biol Chem 1998, Ryu et al., Nature 1999
Text-mined interactions from Literome
Harada et al., J Biol Chem 2003
:
HIPK2 efficiently inhibited
Smad1/4 induced transcription from the
Smad site containing promoter
Matsubara et al., J Biol Chem 2008
:
Furthermore, overexpression of
Smad1 and Smad4 up-regulated Osterix expression, and an inhibitory
Smad , Smad6, markedly
suppressed BMP2 induced Osterix expression in the Runx2-deficient cells
Ellman et al., Gene 2013
:
The synergism results from LfcinB mediated
activation of Sp1 and
SMAD signaling pathways by ( i ) phosphorylation of
SMAD 1/5/8 ; ( ii ) downregulation of SMAD inhibitory factors [ i.e., noggin and SMAD6 ( inhibitory SMAD ) ] ; and ( iii ) upregulation of SMAD4 ( universal co-SMAD )